Alteration of Gut Microbiome Induced by Berberine Improves Visceral Hypersensitivity via Inhibiting Activation of Microglia
Abstract
Background: Accumulating evidence indicates that agents targeting gut dysbiosis are effective on improving symptoms in irritable bowel syndrome (IBS). However, the potential mechanisms remain unclear. Here, we investigated the roles of berberine in modulating the microbiota-gut-brain axis in models of IBS.
Methods: Two models were used to mimic brain-gut axis dysfunction. Specific pathogen-free Sprague Dawley (SD) rats were subjected to water avoidance stress (WAS) and berberine treatment, and germ-free (GF) SD rats underwent fecal microbiota transplantation (FMT) from patient with IBS, followed by berberine or rifaximin gavage. Visceral sensation and depressive behaviors were assessed, colonic tryptase was measured, and microglial activation was evaluated. The fecal microbiota was profiled by 16S rRNA sequencing, and short chain fatty acids (SCFAs) were measured.
Findings: Berberine alleviated stress-induced visceral hypersensitivity and activation of colonic mast cells and microglia. Transfer of fecal samples from berberine-treated stressed donors to GF rats showed protective effects against WAS. IBS-FMT induced visceral hypersensitivity and a pro-inflammatory phenotype of microglia. Berberine, not rifaximin, significantly reversed the activation of microglia, as well as altered microbial composition and function and SCFA profiles in stools of IBS-FMT rats. Pearson correlation analysis revealed positive correlations between SCFA-producing genera or probiotics and the…
Read the paper
Related studies
- Bile Acid 7α-Dehydroxylating Gut Bacteria Secrete Antibiotics that Inhibit Clostridium difficile: Role of Secondary Bile Acids
- Ketogenic diet alleviates colitis by reduction of colonic group 3 innate lymphoid cells through altering gut microbiome
- Altered gut microbiome composition and function are associated with gut barrier dysfunction in healthy relatives of patients with Crohn's disease
- Diet, obesity, and the gut microbiome as determinants modulating metabolic outcomes in a non-human primate model
- Immune Impairment Associated with Vitamin A Deficiency: Insights from Clinical Studies and Animal Model Research
- Glyphosate-based herbicides influence antioxidants, reproductive hormones and gut microbiome but not reproduction: A long-term experiment in an avian model
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.